Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Takahata

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|February 23, 2002
Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudineS Hashino, M Takahata, A Nozawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 1, 1990
[Studies on the sub-MIC of beta-lactam antibiotics--bactericidal activity in compromised host's serum]A Yotsuji, M Takahata, T Yasuda, et al.
Chemical & Pharmaceutical Bulletin|December 1, 1994
Pyridonecarboxylic acids as antibacterial agents. IX. Synthesis and structure-activity relationship of 3-substituted 10-(1-aminocyclopropyl)-9-fluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]- 1,4-benzoxazine-6-carboxylic acids and their 1-thio and 1-aza analoguesY Todo, H Takagi, F Iino, et al.
The Bone & Joint Journal|April 3, 2014
Anomalous vertebral and posterior communicating arteries as a risk factor in instrumentation of the posterior cervical spineK Nagahama, H Sudo, K Abumi, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
Quinolone susceptibility of norA-disrupted Staphylococcus aureusH Yamada, S Kurose-Hamada, Y Fukuda, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinoloneM Takahata, J Mitsuyama, Y Yamashiro, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1982
In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibioticM Tai, Y Fukuoka, A Yotsuji, et al.
The Japanese Journal of Antibiotics|May 1, 1995
[Absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals]S Minami, M Takahata, T Hayashi, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 1997
Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six speciesM Takahata, M Yonezawa, N Matsubara, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 10, 2016
Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemiaM Ota, M Takahata, T Shimizu, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|February 23, 2002
Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudineS Hashino, M Takahata, A Nozawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 1, 1990
[Studies on the sub-MIC of beta-lactam antibiotics--bactericidal activity in compromised host's serum]A Yotsuji, M Takahata, T Yasuda, et al.
Chemical & Pharmaceutical Bulletin|December 1, 1994
Pyridonecarboxylic acids as antibacterial agents. IX. Synthesis and structure-activity relationship of 3-substituted 10-(1-aminocyclopropyl)-9-fluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]- 1,4-benzoxazine-6-carboxylic acids and their 1-thio and 1-aza analoguesY Todo, H Takagi, F Iino, et al.
The Bone & Joint Journal|April 3, 2014
Anomalous vertebral and posterior communicating arteries as a risk factor in instrumentation of the posterior cervical spineK Nagahama, H Sudo, K Abumi, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
Quinolone susceptibility of norA-disrupted Staphylococcus aureusH Yamada, S Kurose-Hamada, Y Fukuda, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinoloneM Takahata, J Mitsuyama, Y Yamashiro, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1982
In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibioticM Tai, Y Fukuoka, A Yotsuji, et al.
The Japanese Journal of Antibiotics|May 1, 1995
[Absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals]S Minami, M Takahata, T Hayashi, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 1997
Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six speciesM Takahata, M Yonezawa, N Matsubara, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 10, 2016
Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemiaM Ota, M Takahata, T Shimizu, et al.
Pageof 6